| Section | Status | CDF | Name |
| 08.01.05 | Formulary |  |
Atezolizumab injection urothelial cancer indications |
| 08.01.05 | Formulary | |
Avelumab injection |
| 08.01.05 | Formulary | |
Axicabtagene ciloleucel cells dispersion for infusion |
| 08.01.01 | Formulary | |
Bendamustine injection |
| 08.01.05 | Formulary | |
Bevacizumab injection |
| 08.01.05 | Formulary | |
Bortezomib injection |
| 08.01.05 | Formulary | |
Brentuximab injection |
| 08.02.04 | Formulary | |
Daratumumab injection |
| 08.01.05 | Formulary | |
Ibrutinib caps |
| 08.02.04 | Formulary | |
Ixazomib caps |
| 08.01.05 | Formulary | |
Niraparib caps |
| 08.01.05 | Formulary | |
Nivolumab injection skin, head and neck and renal cancers |
| 08.01.05 | Formulary | |
Nivolumab injection lung and urothelial cancer |
| 08.02.03 | Formulary | |
Obinutuzumab injection |
| 08.01.05 | Formulary | |
Olaratumab injection |
| 08.01.05 | Formulary | |
Osimertinib tabs |
| 08.01.05 | Formulary | |
Pembrolizumab injection lung cancer indications |
| 08.01.05 | Formulary | |
Pembrolizumab injection Hodgkin lymphoma |
| 08.01.05 | Formulary | |
Pembrolizumab injection urothelial cancer indications |
| 08.01.05 | Formulary | |
Tisagenlecleucel cells dispersion for infusion |
| 08.01.01 | Formulary | |
Venetoclax tabs |